The in vivo application of G‐CSF also led to expansion of NK2/NK3/NKr cells in GBM compared to those in NGBM and GPB; roles of NK2/NK3/NKr cells in allografts and clinical outcome post‐transplantation were still unclear. This evidence concerns the gene CSF3 and glioblastoma.